At Ozon Pharma, the commitment to quality and excellence is woven into the very fabric of the company’s operations. Established in 2017 by Sumitra Jain, Ozon Pharma has made significant strides in the pharmaceutical industry, driven by an unwavering focus on rigorous quality control processes that ensure the safety and efficacy of every product.
Quality assurance begins with the selection of raw materials. Ozon Pharma sources its ingredients from reputable suppliers, each of whom is thoroughly vetted to meet the company’s high standards. This foundational step is critical, as the quality of raw materials directly influences the safety and effectiveness of the final products. Each batch of raw material undergoes stringent testing to verify its identity, purity, and potency before it enters the production process.
Once materials are approved, the manufacturing phase kicks off in state-of-the-art facilities designed to comply with international regulatory standards. Ozon Pharma’s manufacturing plants are equipped with advanced technology and adhere to Good Manufacturing Practices (GMP), ensuring a controlled and sterile environment. These facilities are regularly audited to maintain compliance with regulatory requirements, further underscoring the company’s commitment to quality.
Throughout the manufacturing process, Ozon Pharma employs a series of rigorous quality control checks. Each stage—from formulation to packaging—undergoes meticulous inspection to identify and rectify any deviations from established protocols. Highly trained quality control teams monitor critical parameters, conducting in-process testing to ensure that every aspect of production meets predefined specifications.
One of the hallmarks of Ozon Pharma’s quality assurance is its dedication to stability and shelf-life testing. Understanding that the efficacy of pharmaceutical products can diminish over time, the company conducts extensive stability studies to determine how products behave under various storage conditions. This proactive approach allows Ozon Pharma to provide reliable shelf-life information, ensuring that healthcare providers and patients can trust the integrity of the medications they use.
Additionally, Ozon Pharma emphasizes post-market surveillance as a critical component of its quality management system. The company actively monitors product performance and gathers feedback from healthcare professionals and patients. This data-driven approach allows Ozon Pharma to make informed decisions about product improvements and to swiftly address any safety concerns that may arise.
Journalist Details
